Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1013458 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Monica Sacco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, Facoltà di Medicina e Chirurgia "Agostino Gemelli", Roma, Italy. Hauptthemen laut MEDLINE: Low Density Lipoprotein Receptor-Related Protein-1, von Willebrand Factor, Platelet Glycoprotein GPIb-IX Complex, von Willebrand Diseases. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Catholic University of the Sacred Heart -School of Medicine- Rome, Università Cattolica del Sacro Cuore.
Abstract (Originalsprache)
Type 1 von Willebrand disease (VWD) is often caused by variants in von Willebrand factor (VWF), including p.R1205H (“Vicenza mutation”), which accelerate VWF clearance via macrophage receptor LRP1 and impair platelet adhesion and activation. However, the structural mechanisms underlying these phenotypes remain partially unclear. Here, we use integrative computational modeling (I-TASSER, HADDOCK2.4, and PRODIGY) to predict how p.R1205H/C/L/S variants alter VWF interaction with LRP1 and its platelet receptor GPIbα that binds to the A1 VWF domain. Our models reveal that R1205 acts as a structural hinge: its variants disrupt polar networks in VWF’s D3 domain, exposing neo-epitopes that enhance LRP1 binding (ΔΔG up to −5.3 kcal/mol) while destabilizing the A1 domain’s α1-β2 loop, reducing GPIbα affinity (≅30-fold for R1205L/C). These findings explain clinical observations, p.R1205H rapid clearance yet retained platelet adhesion, and establish R1205 as a dual-functional switch regulating VWF circulatory lifetime and hemostatic activity. This analytical procedure provides a template for predicting pathogenicity of VWF variants and designing targeted therapies for VWD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, Facoltà di Medicina e Chirurgia "Agostino Gemelli", Roma, Italy.
- Servizio Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario "A. Gemell" IRCCS, Roma, Italy.
- Centro Malattie Emorragiche e della Coagulazione, Dipartimento di Oncologia, Ospedale Universitario "Careggi", Firenze, Italy.
ORCID-Profile: Antonietta Ferretti, Raimondo De Cristofaro
Förderung
- Catholic University of the Sacred Heart -School of Medicine- Rome
- Università Cattolica del Sacro Cuore
Zitieren
APA
Sacco, M., Lancellotti, S., Ferretti, A., Basso, M., Di Gennaro, L., Castaman, G., & De Cristofaro, R. (2025). Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013458
Vancouver
Sacco M, Lancellotti S, Ferretti A, Basso M, Di Gennaro L, Castaman G, et al. Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1013458
BibTeX
@article{Sacco2025,
author = {Sacco, Monica and Lancellotti, Stefano and Ferretti, Antonietta and Basso, Maria and Di Gennaro, Leonardo and Castaman, Giancarlo and De Cristofaro, Raimondo},
title = {Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1013458}
}
EUVIMED